Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice

Associations between modifiable factors and the efficacy of cancer immunotherapies remain uncertain. We found previously that diet-induced obesity (DIO) reduces the efficacy of an immunotherapy consisting of adenovirus-encoded TRAIL plus CpG oligonucleotide (AdT/CpG) in mice with renal tumors. To el...

Full description

Bibliographic Details
Main Authors: William J. Turbitt, Shannon K. Boi, Justin T. Gibson, Rachael M. Orlandella, Lyse A. Norian
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/10/2295
_version_ 1797534536939077632
author William J. Turbitt
Shannon K. Boi
Justin T. Gibson
Rachael M. Orlandella
Lyse A. Norian
author_facet William J. Turbitt
Shannon K. Boi
Justin T. Gibson
Rachael M. Orlandella
Lyse A. Norian
author_sort William J. Turbitt
collection DOAJ
description Associations between modifiable factors and the efficacy of cancer immunotherapies remain uncertain. We found previously that diet-induced obesity (DIO) reduces the efficacy of an immunotherapy consisting of adenovirus-encoded TRAIL plus CpG oligonucleotide (AdT/CpG) in mice with renal tumors. To eliminate confounding effects of diet and determine whether outcomes could be improved in DIO mice, we evaluated AdT/CpG combined with anti-CTLA-4 in diet-matched, obese-resistant (OB-RES) versus DIO tumor-bearing mice. Therapy-treated OB-RES mice displayed effective renal tumor control and sustained CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses. In contrast, therapy-treated DIO mice exhibited progressive tumor outgrowth and blunted T cell responses, characterized by reduced intratumoral frequencies of IFNγ<sup>+</sup> CD4<sup>+</sup> and CD8<sup>+</sup> T cells. Weak effector T cell responses in therapy-treated DIO mice were accompanied by low intratumoral concentrations of the T cell chemoattractant CCL5, heightened concentrations of pro-tumorigenic GM-CSF, and impaired proliferative capacity of CD44<sup>+</sup>CD8<sup>+</sup> T cells in tumor-draining lymph nodes. Our findings demonstrate that in lean mice with renal tumors, combining in situ T cell priming upstream of anti-CTLA-4 enhances outcomes versus anti-CTLA-4 alone. However, host obesity is associated with heightened immunotherapy resistance, characterized by multi-factorial deficiencies in effector CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses that extend beyond the tumor microenvironment.
first_indexed 2024-03-10T11:31:58Z
format Article
id doaj.art-a90b3477615e44e4a2cbd0d465a684e0
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T11:31:58Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-a90b3477615e44e4a2cbd0d465a684e02023-11-21T19:13:16ZengMDPI AGCancers2072-66942021-05-011310229510.3390/cancers13102295Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing MiceWilliam J. Turbitt0Shannon K. Boi1Justin T. Gibson2Rachael M. Orlandella3Lyse A. Norian4Department of Nutrition Sciences, University of Alabama at Birmingham (UAB), Birmingham, AL 35233, USAGraduate Biomedical Sciences, University of Alabama at Birmingham (UAB), Birmingham, AL 35233, USAGraduate Biomedical Sciences, University of Alabama at Birmingham (UAB), Birmingham, AL 35233, USAGraduate Biomedical Sciences, University of Alabama at Birmingham (UAB), Birmingham, AL 35233, USADepartment of Nutrition Sciences, University of Alabama at Birmingham (UAB), Birmingham, AL 35233, USAAssociations between modifiable factors and the efficacy of cancer immunotherapies remain uncertain. We found previously that diet-induced obesity (DIO) reduces the efficacy of an immunotherapy consisting of adenovirus-encoded TRAIL plus CpG oligonucleotide (AdT/CpG) in mice with renal tumors. To eliminate confounding effects of diet and determine whether outcomes could be improved in DIO mice, we evaluated AdT/CpG combined with anti-CTLA-4 in diet-matched, obese-resistant (OB-RES) versus DIO tumor-bearing mice. Therapy-treated OB-RES mice displayed effective renal tumor control and sustained CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses. In contrast, therapy-treated DIO mice exhibited progressive tumor outgrowth and blunted T cell responses, characterized by reduced intratumoral frequencies of IFNγ<sup>+</sup> CD4<sup>+</sup> and CD8<sup>+</sup> T cells. Weak effector T cell responses in therapy-treated DIO mice were accompanied by low intratumoral concentrations of the T cell chemoattractant CCL5, heightened concentrations of pro-tumorigenic GM-CSF, and impaired proliferative capacity of CD44<sup>+</sup>CD8<sup>+</sup> T cells in tumor-draining lymph nodes. Our findings demonstrate that in lean mice with renal tumors, combining in situ T cell priming upstream of anti-CTLA-4 enhances outcomes versus anti-CTLA-4 alone. However, host obesity is associated with heightened immunotherapy resistance, characterized by multi-factorial deficiencies in effector CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses that extend beyond the tumor microenvironment.https://www.mdpi.com/2072-6694/13/10/2295diet-induced obesitycancer therapyimmunotherapyT cells
spellingShingle William J. Turbitt
Shannon K. Boi
Justin T. Gibson
Rachael M. Orlandella
Lyse A. Norian
Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
Cancers
diet-induced obesity
cancer therapy
immunotherapy
T cells
title Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
title_full Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
title_fullStr Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
title_full_unstemmed Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
title_short Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
title_sort diet induced obesity impairs outcomes and induces multi factorial deficiencies in effector t cell responses following anti ctla 4 combinatorial immunotherapy in renal tumor bearing mice
topic diet-induced obesity
cancer therapy
immunotherapy
T cells
url https://www.mdpi.com/2072-6694/13/10/2295
work_keys_str_mv AT williamjturbitt dietinducedobesityimpairsoutcomesandinducesmultifactorialdeficienciesineffectortcellresponsesfollowingantictla4combinatorialimmunotherapyinrenaltumorbearingmice
AT shannonkboi dietinducedobesityimpairsoutcomesandinducesmultifactorialdeficienciesineffectortcellresponsesfollowingantictla4combinatorialimmunotherapyinrenaltumorbearingmice
AT justintgibson dietinducedobesityimpairsoutcomesandinducesmultifactorialdeficienciesineffectortcellresponsesfollowingantictla4combinatorialimmunotherapyinrenaltumorbearingmice
AT rachaelmorlandella dietinducedobesityimpairsoutcomesandinducesmultifactorialdeficienciesineffectortcellresponsesfollowingantictla4combinatorialimmunotherapyinrenaltumorbearingmice
AT lyseanorian dietinducedobesityimpairsoutcomesandinducesmultifactorialdeficienciesineffectortcellresponsesfollowingantictla4combinatorialimmunotherapyinrenaltumorbearingmice